Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    21526923 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
Conditions: Age-Related Macular Degeneration;   Polypoidal Choroidal Vasculopathy;   Pathological Myopia;   Conbercept;   Pharmacogenomic
Intervention: Drug: Intravitreal injection of conbercept
2 Recruiting Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)
Condition: Macular Edema, Diabetic
Intervention: Drug: aflibercept
3 Active, not recruiting
Has Results
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
Condition: Age Related Macular Degeneration
Interventions: Drug: ranibizumab;   Drug: bevacizumab
4 Completed
Has Results
Study for Recalcitrant Age Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: aflibercept 2.0 mg
5 Recruiting Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD
Condition: Neovascular Age-related Macular Degeneration
Interventions: Procedure: 1+PRN;   Procedure: 3+PRN;   Drug: Ranibizumab
6 Active, not recruiting Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Condition: Macular Degeneration
Intervention: Drug: 0.5mg ranibizumab

Study has passed its completion date and status has not been verified in more than two years.